scispace - formally typeset
Open AccessJournal ArticleDOI

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

Hannele Yki-Järvinen, +3 more
- 01 Aug 2000 - 
- Vol. 23, Iss: 8, pp 1130-1136
Reads0
Chats0
TLDR
Use of insulin glargine instead of NPH in insulin combination regimens in type 2 diabetes is associated with less nocturnal hypoglycemia and lower post-dinner glucose levels, consistent with peakless and longer duration of action of insulinglargine compared with NPH.
Abstract
OBJECTIVE: Available basal insulin formulations do not provide a constant and reliable 24-h insulin supply. We compared the efficacy and safety of glargine (a long-acting insulin analog) and NPH insulins in insulin-naive type 2 diabetic patients treated with oral antidiabetic agents. RESEARCH DESIGN AND METHODS: There were 426 type 2 diabetic patients (age 59 +/- 9 years, BMI 28.9 +/- 4.3 kg/m2, mean +/- SD) with poor glycemic control on oral antidiabetic agents randomized to treatment for 1 year with bedtime insulin glargine or bedtime NPH insulin. Oral agents were continued unchanged. The fasting blood glucose (FBG) target was 6.7 mmol/l (120 mg/dl). RESULTS: Average glycemic control improved similarly with both insulins (HbA(1c), [reference range

read more

Citations
More filters
Journal ArticleDOI

The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

TL;DR: Systematically titrating bedtime basal insulin added to oral therapy can safely achieve 7% HbA(1c) in a majority of overweight patients with type 2 diabetes, thus reducing a leading barrier to initiating insulin.
Book

Hypoglycemia in Diabetes

TL;DR: Pending the prevention and cure of diabetes or the development of methods that provide glucose-regulated insulin replacement or secretion, the authors need to learn to replace insulin in a much more physiological fashion, to prevent, correct, or compensate for compromised glucose counterregulation, or both if they are to achieve near-euglycemia safely in most people with diabetes.
Journal ArticleDOI

Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes: A Randomized Trial

TL;DR: This multicenter, 26-week, randomized trial compared the addition of exenatide or insulin glargine to regimens of 551 patients with suboptimally controlled type 2 diabetes, and found both additions led to similar reductions in hemoglobin A1c levels.
References
More filters
Journal ArticleDOI

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

TL;DR: Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM.
Book ChapterDOI

In the Netherlands

TL;DR: The major Reformation of the 16th century is represented in the Netherlands most clearly by Cassander, Coornhert and Lipsius as mentioned in this paper, who follow one another chronologically in this order and they show in that order an increasing subjection to the influence of the Classics and a reduced need of supernatural salvation in the christian sense.
Journal ArticleDOI

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial.

TL;DR: In this article, a randomized controlled trial was conducted to determine whether bedtime insulin regimens differ with respect to their effects on weight gain in patients with type 2 diabetes, and the results showed that combination therapy with oral hypoglycemic agents and bedtime-intermediate-acting insulin produces similar improvement in glycemic control but induces less weight gain.
Journal ArticleDOI

Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis.

TL;DR: Combined insulin-sulfonylurea therapy leads to modest improvement in glycemic control compared with insulin therapy alone and obese patients with higher fasting C-peptides may be more likely to respond than others.
Related Papers (5)

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

R C Turner, +398 more
- 12 Sep 1998 -